BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohelnikova-Duchonova B, Marsakova L, Vrana D, Holcatova I, Ryska M, Smerhovsky Z, Slamova A, Schejbalova M, Soucek P. Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk. Pancreas 2011;40:72-8. [PMID: 20966810 DOI: 10.1097/MPA.0b013e3181f74ad7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang P, Zhu Y, Xi S, Li S, Zhang Y. Association between MnSOD Val16Ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls. Dis Markers 2018;2018:3061974. [PMID: 30245752 DOI: 10.1155/2018/3061974] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
2 Wilkes JG, Alexander MS, Cullen JJ. Superoxide Dismutases in Pancreatic Cancer. Antioxidants (Basel) 2017;6:E66. [PMID: 28825637 DOI: 10.3390/antiox6030066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
3 Martinez-Useros J, Li W, Cabeza-Morales M, Garcia-Foncillas J. Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment. J Clin Med 2017;6:E29. [PMID: 28282928 DOI: 10.3390/jcm6030029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
4 Mohelnikova-Duchonova B, Strouhal O, Hughes DJ, Holcatova I, Oliverius M, Kala Z, Campa D, Rizzato C, Canzian F, Pezzilli R, Talar-Wojnarowska R, Malecka-Panas E, Sperti C, Federico Zambon C, Pedrazzoli S, Fogar P, Milanetto AC, Capurso G, Delle Fave G, Valente R, Gazouli M, Malleo G, Teresa Lawlor R, Strobel O, Hackert T, Giese N, Vodicka P, Vodickova L, Landi S, Tavano F, Gioffreda D, Piepoli A, Pazienza V, Mambrini A, Pedata M, Cantore M, Bambi F, Ermini S, Funel N, Lemstrova R, Soucek P. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival. Sci Rep 2017;7:43812. [PMID: 28272475 DOI: 10.1038/srep43812] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yu H, Liu H, Wang LE, Wei Q. A functional NQO1 609C& gt; T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS One. 2012;7:e30566. [PMID: 22272361 DOI: 10.1371/journal.pone.0030566] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
6 Xiang M, Feng J, Geng L, Yang Y, Dai C, Li J, Liao Y, Wang D, Du XB. Sera total oxidant/antioxidant status in lung cancer patients. Medicine (Baltimore) 2019;98:e17179. [PMID: 31517874 DOI: 10.1097/MD.0000000000017179] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lajin B, Alachkar A. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer 2013;109:1325-37. [PMID: 23860519 DOI: 10.1038/bjc.2013.357] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
8 Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, Tan X, Cunningham JM, Li Y, Rider DN, Oberg AL, Rabe KG, Anderson KE, Sinha R, Petersen GM. Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk. Pancreas 2013;42:1043-53. [PMID: 24051964 DOI: 10.1097/MPA.0b013e3182968e00] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Olsen RK, Cornelius N, Gregersen N. Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism. J Inherit Metab Dis 2015;38:703-19. [PMID: 26025548 DOI: 10.1007/s10545-015-9861-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
10 Huang Q, Feng J, Wu R, Yang Y, Dai C, Li J, Liao Y, Xiang M, Wang D, Du XB. Total Oxidant/Antioxidant Status in Sera of Patients with Esophageal Cancer. Med Sci Monit 2017;23:3789-94. [PMID: 28777781 DOI: 10.12659/msm.902210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Megarity CF, Gill JR, Caraher MC, Stratford IJ, Nolan KA, Timson DJ. The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties. FEBS Lett 2014;588:1666-72. [PMID: 24631540 DOI: 10.1016/j.febslet.2014.02.063] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
12 O'Leary BR, Carroll RS, Steers GJ, Hrabe J, Domann FE, Cullen JJ. Impact of EcSOD Perturbations in Cancer Progression. Antioxidants (Basel) 2021;10:1219. [PMID: 34439467 DOI: 10.3390/antiox10081219] [Reference Citation Analysis]